Checchi Capital Advisers LLC Has $240,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Checchi Capital Advisers LLC raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 34.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,063 shares of the pharmacy operator’s stock after buying an additional 1,542 shares during the quarter. Checchi Capital Advisers LLC’s holdings in Walgreens Boots Alliance were worth $240,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. GoalVest Advisory LLC raised its stake in shares of Walgreens Boots Alliance by 10,828.6% in the second quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 758 shares in the last quarter. WFA of San Diego LLC acquired a new position in shares of Walgreens Boots Alliance in the second quarter valued at $32,000. Tompkins Financial Corp raised its stake in shares of Walgreens Boots Alliance by 215.7% in the first quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 647 shares in the last quarter. Tcwp LLC acquired a new position in shares of Walgreens Boots Alliance in the first quarter valued at $51,000. Finally, Valley National Advisers Inc. raised its stake in shares of Walgreens Boots Alliance by 476.0% in the first quarter. Valley National Advisers Inc. now owns 1,152 shares of the pharmacy operator’s stock valued at $52,000 after purchasing an additional 952 shares in the last quarter. 57.33% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Walgreens Boots Alliance

In related news, EVP Kevin M. Ban sold 10,303 shares of the firm’s stock in a transaction dated Friday, November 18th. The stock was sold at an average price of $40.19, for a total value of $414,077.57. Following the transaction, the executive vice president now owns 27,916 shares in the company, valued at $1,121,944.04. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $39.89, for a total value of $660,977.30. Following the transaction, the director now owns 5,515 shares of the company’s stock, valued at $219,993.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Kevin M. Ban sold 10,303 shares of the stock in a transaction dated Friday, November 18th. The shares were sold at an average price of $40.19, for a total value of $414,077.57. Following the completion of the transaction, the executive vice president now directly owns 27,916 shares in the company, valued at approximately $1,121,944.04. The disclosure for this sale can be found here. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $41.76 on Thursday. The stock’s fifty day moving average is $35.22 and its 200-day moving average is $38.10. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.38 and a current ratio of 0.75. The stock has a market capitalization of $36.11 billion, a PE ratio of 8.35, a PEG ratio of 1.86 and a beta of 0.71. Walgreens Boots Alliance, Inc. has a 52 week low of $30.39 and a 52 week high of $55.00.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last announced its earnings results on Thursday, October 13th. The pharmacy operator reported $0.80 EPS for the quarter, topping the consensus estimate of $0.77 by $0.03. The company had revenue of $32.45 billion for the quarter, compared to analysts’ expectations of $32.17 billion. Walgreens Boots Alliance had a return on equity of 14.39% and a net margin of 3.27%. The business’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.17 earnings per share. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 4.5 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Investors of record on Tuesday, November 15th will be issued a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 4.60%. The ex-dividend date of this dividend is Monday, November 14th. Walgreens Boots Alliance’s dividend payout ratio is 38.40%.

Wall Street Analyst Weigh In

WBA has been the subject of a number of recent research reports. Morgan Stanley restated an “underweight” rating and issued a $39.00 target price on shares of Walgreens Boots Alliance in a research note on Wednesday. Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and upped their price target for the company from $43.00 to $54.00 in a research report on Tuesday. Mizuho lowered their price target on Walgreens Boots Alliance to $36.00 in a research report on Thursday, October 13th. StockNews.com cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Wednesday, October 5th. Finally, Royal Bank of Canada lowered their price target on Walgreens Boots Alliance from $42.00 to $36.00 and set a “sector perform” rating on the stock in a research report on Wednesday, October 19th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $43.23.

Walgreens Boots Alliance Company Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.